Rich Barron - Publications, H-index & Citations

Rich Barron

Amgen

23H指数

75论文数

1.9K被引数

收录论文 23

发表时间

Determinants of imminent fracture risk in postmenopausal women with osteoporosis 绝经后骨质疏松妇女即将发生骨折风险的决定因素

OSTEOPOROSIS INTERNATIONAL

IF5.4

2020-07-01

OAAI

Barron, R. L.; Oster, G.; Grauer, A.; Crittenden, D. B.; Weycker, D.

Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian Multicentre Osteoporosis Study (CaMos)

ARCHIVES OF OSTEOPOROSIS

IF2.8

2019-05-16

PREAI

Adachi, Jonathan D.; Berger, Claudie; Barron, Rich; Weycker, Derek; Anastassiades, Tassos P.; Davison, K. Shawn; Hanley, David A.; Ioannidis, George; Jackson, Stuart A.; Josse, Robert G.; Kaiser, Stephanie M.; Kovacs, Christopher S.; Leslie, William D.; Morin, Suzanne N.; Papaioannou, Alexandra; Prior, Jerilynn C.; Shyta, Erinda; Silvia, Amanda; Towheed, Tanveer; Goltzman, David

Changes in bone mineral density (BMD): a longitudinal study of osteoporosis patients in the real-world setting

ARCHIVES OF OSTEOPOROSIS

IF2.8

2018-11-12

PREAI

Berry, S. D.; Dufour, A. B.; Travison, T. G.; Zhu, H.; Yehoshua, A.; Barron, R.; Recknor, C.; Samelson, E. J.

EXPERTS IN HEALTH TECHNOLOGY ASSESSMENT ARE CONCERNED ABOUT THE TRANSLATION FROM EVIDENCE TO DECISION-MAKING

VALUE IN HEALTH

IF6

2018-10-01

OAAI

Shih, T.; Toor, K.; Yoon, L.; Barron, R.; Cope, S.; Huber, C.; Arellano, J.; Jansen, J. P.

Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review

ARCHIVES OF OSTEOPOROSIS

IF2.8

2018-05-08

OAAI

Fujiwara, Saeko; Miyauchi, Akimitsu; Hamaya, Etsuro; Nicholls, Rebecca Jayne; Weston, Adele; Baidya, Santwona; Pinto, Lionel; Barron, Rich; Takada, Junichi

Treatment patterns in patients with osteoporosis at high risk of fracture in Japan: retrospective chart review 日本高危骨折骨质疏松患者的治疗模式: 回顾性图表回顾

ARCHIVES OF OSTEOPOROSIS

IF2.8

2018-03-22

PREAI

Fujiwara, Saeko; Miyauchi, Akimitsu; Hamaya, Etsuro; Nicholls, Rebecca Jayne; Weston, Adele; Baidya, Santwona; Pinto, Lionel; Barron, Rich; Takada, Junichi

Predictors of near-term fracture in osteoporotic women aged ae65 years, based on data from the study of osteoporotic fractures

OSTEOPOROSIS INTERNATIONAL

IF5.4

2017-06-07

OAAI

Weycker, D.; Edelsberg, J.; Barron, R.; Atwood, M.; Oster, G.; Crittenden, D. B.; Grauer, A.

Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data 使用美国索赔数据预测50岁或50岁以上骨质疏松症患者的即将发生骨折的风险

ARCHIVES OF OSTEOPOROSIS

IF2.8

2016-07-30

OAAI

Bonafede, M.; Shi, N.; Barron, R.; Li, X.; Crittenden, D. B.; Chandler, D.

COST EFFECTIVENESS OF PEGFILGRASTIM FOR REDUCING INCIDENCE OF FEBRILE NEUTROPENIA EVENTS AFTER CYTOTOXIC CHEMOTHERAPY FOR SOLID TUMORS IN TURKEY

VALUE IN HEALTH

IF6

2016-05-01

OAAI

Saka, G.; Villa, G.; Worth, G.; Barron, R.; Malhan, S.; Lyman, G. H.

A prospective study of patterns of chemotherapy, colony-stimulating factor use, and burden of colony-stimulating factor injections in patients with early-stage breast cancer

CANCER RESEARCH

IF16.6

2016-02-15

PREAI

Li, X.; Barron, R.; Tzivelekis, S.; Li, Y.; Chandler, D.; Xu, H.; Morrow, P. K.; Klippel, Z.; Nagarajan, A.; Reiner, M.; Page, J. H.

Importance of Risk Factors for Febrile Neutropenia Among Patients Receiving Chemotherapy Regimens Not Classified as High-Risk in Guidelines for Myeloid Growth Factor Use

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2015-08-13

OAAI

Weycker, Derek; Li, Xiaoyan; Barron, Rich; Wu, Hongsheng; Morrow, P. K.; Xu, Hairong; Reiner, Maureen; Garcia, Jacob; Mhatre, Shivani K.; Lyman, Gary H.

COST-EFFECTIVENESS OF PRIMARY PROPHYLAXIS WITH PEGFILGRASTIM VS LIPEGFILGRASTIM TO REDUCE THE INCIDENCE OF FEBRILE NEUTROPENIA IN PATIENTS WITH EARLY STAGE BREAST CANCER OR NON-HODGKIN LYMPHOMA

VALUE IN HEALTH

IF6

2015-05-01

OAAI

Fust, K.; Li, X.; Maschio, M.; Villa, G.; Parthan, A.; Barron, R.; Weinstein, M. C.; Somers, L.; Hoefkens, C.; Lyman, G. H.

Risk and consequences of neutropenic complications with adjuvant use of trastuzumab and chemotherapy in women with metastatic breast cancer

CANCER RESEARCH

IF16.6

2013-12-15

PREAI

Weycker, D.; Li, X.; Kartashov, A.; Barron, R.; Edelsberg, J.; Xu, H.; Girardi, V.; Lyman, G.

Relative dose intensity of taxane-based chemotherapy in patients with stage IV breast cancer

CANCER RESEARCH

IF16.6

2013-12-15

PREAI

Denduluri, N.; Havrilesky, L.; Bhor, M.; Bhowmik, D.; Morrow, P. K.; Watson, H.; Dhanda, R.; Li, X.; Chung, H.; Saravanan, S.; Barron, R.; Crawford, J.

COST-EFFECTIVENESS OF PROPHYLAXIS TREATMENT STRATEGIES FOR FEBRILE NEUTROPENIA IN RECURRENT OVARIAN CANCER PATIENTS

VALUE IN HEALTH

IF6

2013-05-01

OAAI

Fust, K.; Li, X.; Maschio, M.; Barron, R.; Weinstein, M. C.; Parthan, A.; Walli-Attaei, M.; Chandler, D. B.; Lyman, G. H.

Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice 美国临床实践中早期乳腺癌女性化疗相对剂量强度降低的发生率

BREAST CANCER RESEARCH AND TREATMENT

IF3

2012-01-24

PREAI

Weycker, Derek; Barron, Rich; Edelsberg, John; Kartashov, Alex; Lyman, Gary H.